Vanguard (HIMS) reports 0 shares after internal realignment — Schedule 13G/A
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 5 to its Schedule 13G/A reporting on Hims & Hers Health Inc. common stock. The amendment states amount beneficially owned: 0 and percent of class: 0%, reflecting an internal realignment described as being made “in accordance with SEC Release No. 34-39538 (January 12, 1998).”
The filing explains certain subsidiaries or business divisions will report beneficial ownership separately after the realignment. The filing is signed by Ashley Grim, Head of Global Fund Administration.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Vanguard report owning in HIMS on this Schedule 13G/A amendment?
It reports 0 shares and 0% ownership. The amendment states the holding is zero after an internal realignment and separate reporting by subsidiaries under SEC Release No. 34-39538.
Why does The Vanguard Group show zero ownership in the HIMS filing?
Because of an internal realignment completed January 12, 2026, causing subsidiaries to report separately. The filing cites SEC Release No. 34-39538 (January 12, 1998) as the basis for disaggregation.
Does the amendment identify any subsidiary beneficiaries or holdings for HIMS?
No specific subsidiary holdings are listed in this amendment. It states certain subsidiaries will report beneficial ownership separately but does not name those entities here.
Who signed the Schedule 13G/A amendment for Vanguard and when?
The filing is signed by Ashley Grim, Head of Global Fund Administration with a signature date of 03/27/2026 as shown in the filing excerpt.